| Tag | Content |
|---|
EnhancerAtlas ID | HS105-54909 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr3:33478730-33481220 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GFI1 | MA0038.2 | chr3:33480613-33480625 | GCAATCACTGCA | + | 6.14 | | MSC | MA0665.1 | chr3:33479996-33480006 | AACAGCTGTT | + | 6.02 | | MSC | MA0665.1 | chr3:33479996-33480006 | AACAGCTGTT | - | 6.02 | | MYF6 | MA0667.1 | chr3:33479996-33480006 | AACAGCTGTT | + | 6.02 | | MYF6 | MA0667.1 | chr3:33479996-33480006 | AACAGCTGTT | - | 6.02 | | NFIA | MA0670.1 | chr3:33480063-33480073 | GGTGCCAAGT | + | 6.02 | | SNAI2 | MA0745.2 | chr3:33478809-33478819 | AACAGGTGCA | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10047 | chr3:33477892-33484075 | CD14 | | SE_54375 | chr3:33479695-33483578 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTTAAGAGAA AGGGGTGGGG GGAAACAACA AAAGAGAAGG GGGTCTCATT CTTGCCCAGG 60
CTGGAATGCA GTGGCTATTA ACAGGTGCAA TCATAGCACA CACTACACCC CTGAACCTCT 120
GGGCTCAAGC AATCTCCCAC GTAGCTAGGT CTACAAGCAT ACCAAACATC ACACCTGCCT 180
AATTTTAAGT CAGACCACTG ACAGAAGCCA TTTCTTCCTT TCAAACTATC CTCCCAAAAG 240
ATGAGGAAAC CATTCCCTAA GAGAAGTCTT TTAAGAAATA CCTCTTGTTT TAAGCCATCC 300
AAAAAGCAAA TACAGTAAGC ATGTTTCATT TTGAAAGAAA AATAGAAAGC TGCCTACAAA 360
ATCAATTTGT ATCAAGAAGT CATTTTTCCA GTAATTTCTT CAAGTTTACT TCTTGAACTT 420
TGAAAGATAA GCTTTCCTTC CCACTGGATG CCAGAGGAAG TGACTGAATG CTCAAGCTGG 480
CCATTCATAG GCACTCCAAC CCTCTCAGGG CTCCAGGGCC AGGCATGGAA AGTACAACTG 540
CAGTCCAGGG AGGCCTGCAG CAGCTAACGC CTTCTTCAGA TTTTCTCCTT ATCGAGTCAA 600
TTTTGGAATT TCCTTAGTTT GAGAATTTCA AACAAAGGGC CTTGAATTTG CAAGAGGCAA 660
GCACTCTCAT CTCTTAGTTT TTGAGGACTC AATTAAATAC GAAAAAAAAA CCTTCTTAAA 720
AATGGTAATT ACCTTCAAAC TTCTTTGAAA ATTTAGATTA AATGACACAA CCAAAAAAGA 780
ATTCAAGGGA AAATTATCCC TGTAAAGAGT ACTGTAGGTT ACACAGAATT ACAAAGATCT 840
CACACATTAC TTTAAAAATA CATGGTCAGG GAAAGGTTTA AAATCATCAA GATTGTACTT 900
CCTTTTCATG GAAATAAACC ATACACAGAA GTTATTACAT TAATAAGTTG GCTGAATCAC 960
TAAATCAAAG TACAGGTCAA ATAAAACCCT AGAAAAAAGT AAAAGCTCAA AATAGCTATC 1020
AATAAGTAAA CTTTTCAGCA GCAAACTTTC ATTTTACCAT AAAAGAGAAG CAACTGAGGA 1080
GAGACACATA TTGAACTTGC TTCACGTGCC TCCTTTGCCT TGACTATAAG CCTCGTGTTT 1140
CCAGTAGAGA GCTAAGGAGC AGAATGGCAC TAGAGGAGTG CGTTTTCACT AGAGAAGCAC 1200
TGCCTCTAAT ACTCCCCTCT GGGGTGACTC CATGACTTTC AGTAGCTCAA TTTCCTCAAC 1260
AACTGAAACA GCTGTTTTAG AAAATAAGCC AACTCATCTA CAGGCCTTAA GTTATACAAC 1320
TGCAGAGAGA AGAGGTGCCA AGTTCAGGAA GCCCAACAGA GACCAAATCA GAGCCAGACG 1380
CTGGGGAACT CCAGGTTTAA TATGCCTTCC ACTACTCACT TCCACACTCC AAGAAATGTC 1440
TCCAACCTTT CTGAGAGTTC TTTATGGCTC AGAATTTCTC CTTAAGATTT AAAGACCCAA 1500
TTACTTCAAG GAGCAGCCAC CAAGATTCCA GGCCAGCTTT AACCCAGAAG TCCTCCTCTA 1560
GAGCTGCAGT AAGATGTATG AATGCTACTG GGAAACTGTA GAGCACTTCC AAAACATCAG 1620
ACATTTTCTA AAGAACAGAA AGCTACACTT AATTCACATT ATTGAAAAGC TGCCAAACCA 1680
CTGATTTTTA GACTTTATTA GTCAAGTCAA CGCTATGGTA AACTATATTT CAATAAAGCC 1740
ACTAAAAAAA TACAGAGTTT CCAAATTCCT AACAGTTAAA AAGGATAAAG GGCGGAGACT 1800
AAGCTCAGAT CTGTTTCAAT CTCTCCATAT TAAAATGAAT GACTGCTGGT ACAGACAGCA 1860
GAGACTAAAC AATTATTTGT GGTGCAATCA CTGCATCTTA AAACCCTCAA GAGGAAACAG 1920
CCTGAGAGGG TAGTCTCCAA AATGAGAAAC TTCACTTTGA GACAATCAAA AGAACAAAAC 1980
GAAGTCACAG TGCTACTCCC ACCGCTGCTC TTTCAATTAT AATTTACTAA CATCAAGTGA 2040
TTAAAATCTG CAGCCAGAAA AGATCATAAT GTAGGACAAC AAAGTAGGAA CTGATCCCAA 2100
AACGCTAGAC AGTATTCTCC CAATATAAGT GCTGCCTTTT CGTACAGTGT ATTCTAGCTC 2160
CAATGGGACT TGTAAATCAC TTATAAGGAA AAGAAGCCCC TTCCCCCACC AACCCAAGCC 2220
ATCCTAATAG CTGGGCGTGT TTTACAGCAA ATATGAAGCA CTCAGGAGCG GTCCGAGGCC 2280
GACGCTTGCG GGGCCATCCT CCCCCACCCG CCCGTCACCA GGGCGAGCAG AGGCCTTTGG 2340
GGTTCCATGG CCCCCGACCG CCACGCGGCA GGACTCCGAC CCCGCAGCCC AGGAGGCCCG 2400
CGCACCTCTG GGAGCAGCCG CATCTGGCAG AGACTCAGGG CTGCGCAGGC CTTCCCCAAG 2460
GAGACAGAGG CTTCTCCCCG CCCAGGGAGC 2490
|
